Navigation Links
Task Force Recommends Screening for Hearing Loss in All Newborns
Date:7/3/2008

ROCKVILLE, Md., July 3 /PRNewswire-USNewswire/ -- All newborn infants should be screened for congenital hearing loss that is present at birth, according to a new recommendation from the U.S. Preventive Services Task Force. The recommendation and the accompanying summary of evidence appear in the July 7 issue of Pediatrics.

Children whose hearing is impaired at birth, during infancy or in early childhood can have problems with verbal and nonverbal communication and social skills, increased behavioral problems, and lower academic achievement compared with children with normal hearing. Infants at high risk for hearing loss include those who have spent more than 2 days in a neonatal intensive care unit; those diagnosed with certain syndromes, such as Waardenburg or Usher syndrome; and those with a family history of childhood hearing loss. Because half of infants with hearing loss have no identifiable risk factors, the Task Force proposes universal screening, rather than targeted screening. Detecting and treating infants for hearing loss, rather than detecting it at a later age, provides better chances for positive outcomes such as stronger language skills.

For every 1,000 infants born in the United States, congenital hearing loss occurs in between one and three infants. Congenital hearing loss happens more frequently than other conditions typically screened for as part of a health care evaluation. Infants should be screened before they are 1 month old; those who do not pass the screening should receive further hearing and medical evaluation before they are 3 months old. Thirty-nine U.S. states have enacted legislation related to universal newborn hearing screening. Laws differ on whether screening is mandated or encouraged, how results are reported and how screening is funded.

"Screening for hearing loss should be part of every newborn infant's health care evaluation," said Task Force Chair Ned Calonge, M.D., who is also chief medical officer
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
2. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
3. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
4. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
5. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
6. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
7. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
8. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
9. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
10. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
11. Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
(Date:6/29/2015)... ... June 29, 2015 , ... Mediaplanet has released ... of USA TODAY. This 12-page, glossy, full-color special section hit newsstands Friday, June ... markets totaling approximately 450,000 copies, with an estimated readership of 1.3 million. The ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... government contractors, nonprofits, independent schools, and other growing businesses across the United States, ... 100 Value Added Resellers for the fifth consecutive year. , Based on company ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... new approach to build nearly complete genomes by combining high-throughput DNA sequencing with ... critically important for their association with human disease, but previously difficult to detect. ...
(Date:6/29/2015)... ... June 29, 2015 , ... San Fernando Valley skin doctor ... sagging skin. Ulthera is a special treatment that offers a way to firm sagging ... gently stimulate collagen production. Ulthera is highly targeted and precise to help reduce treatment ...
(Date:6/29/2015)... ... ... The Food Safety and Technology Research Centre under the ... (PolyU) has developed a new method for rapid authentication of edible oils and ... in food safety, and becomes particularly important with the emergence and widespread use ...
Breaking Medicine News(10 mins):Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2
... a Two-Year Term as Co-Chair of the PSWGSAN FRANCISCO, ... that this release was issued previously on January 22, ... Dr. Ali Rashidee MD, MS, the Director ... elected Co-Chair for the HL7 Patient Safety Work Group ...
... Jan. 25 International Medical Corps (IMC) and ... of understanding (MoU) that outlines plans to enhance ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070406/LAF015LOGO )The two parties agreed ... development settings to provide rapid response to populations ...
... in recalls as salmonella outbreak action continues; Girl Scouts, Hershey ... Jan. 24 (HealthDay News) -- Another person has died from ... bringing the nationwide number to seven. , According to a ... officials say the death of an elderly Minnesota woman Jan. ...
... and English Language Review Centers Opened in Asia by VisionQwest ... ... -- VisionQwest Resource Group, Inc. has begun to expand its review ... in Bangkok, Thailand. The review center in the Philippines has ...
... to hysterectomy, researchers note , , FRIDAY, Jan. 23 ... thought need additional surgery to stop excessive or ... hysterectomy called global endometrial ablation (GEA), a new ... has been regarded as being just as effective ...
... Wagner named Managing Director in EuropeNEW YORK, Jan. 23 ... consulting firm, appointed John Karonis President of its Retail ... Mark Wietecha, Chairman of KSA.Karonis was formerly Managing Director, ... oversight for the firm,s retail practices in Asia and ...
Cached Medicine News:Health News:Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Work Group (PSWG) at HL7 2Health News:Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Work Group (PSWG) at HL7 3Health News:International Medical Corps and Agility Logistics Partner to Enhance Delivery of Humanitarian Relief 2Health News:International Medical Corps and Agility Logistics Partner to Enhance Delivery of Humanitarian Relief 3Health News:Seventh Salmonella Death Linked to Peanut Products 2Health News:Seventh Salmonella Death Linked to Peanut Products 3Health News:VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia 2Health News:VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia 3Health News:VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia 4Health News:Menstrual Bleeding Treatment Safer Than Thought 2Health News:Kurt Salmon Associates Names John Karonis President of Retail and Consumer Products Group 2
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: